Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Super-Bolus vs Normal-Bolus in Children with Type 1 Diabetes
NCT04019821Phase 4Completed
- Sponsor
- Medical University of Warsaw
- Start
- Jan 2020
- Primary completion
- Jan 2023
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin aspart, insulin glulisine and insulin lispro in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Medical University of Warsaw. Primary endpoint: Postprandial Glycemia. Started Jan 2020; status: completed.
02
Drugs
insulin aspartinsulin glulisineinsulin lispro
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT04019821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04019821.